Pharma Mar SA(DE:PMRA)
€62.20-2.00 (-3.12%)
DE:PMRA
Pharma Mar SA earnings date
€62.20
At close:-2.00 (-3.12%)
Pharma Mar SA (PMRA) Q3 2026 Earnings Report
0 Followers
DE:PMRA Q3 2026 EPS Results
- Actual EPS
- EUR 0.46
- Consensus EPS
- EUR 0.13
- Beat/Miss
- Beat by +EUR 0.33
- One Year Ago EPS
- -EUR 0.13
DE:PMRA Q3 2026 Revenue Results
- Actual Revenue
- EUR 54.42M
- Expected Revenue
- EUR 52.00M
- Beat/Miss
- Beat by +EUR 2.41M
- YoY Revenue Growth
- +52.58%
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 10/29/2026
- Time
- TBA
- Conference Call
- Thursday, October 29, 2026
DE:PMRA Upcoming Earnings
Pharma Mar SA's next earnings date is estimated for March 1, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:PMRA Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 01, 2027 | 2026 (Q4) | 0.40- | 3.33 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 0.130.46 | -0.13 | 453.85% (+0.59) | |
| Jul 29, 2026 | 2026 (Q2) | 0.18-0.06 | 1.32 | -104.53% (-1.39) | |
| Apr 23, 2026 | 2026 (Q1) | 0.130.09 | -0.11 | 181.82% (+0.20) | |
| Feb 27, 2026 | 2025 (Q4) | 3.073.33 | 1.04 | 219.14% (+2.29) | |
| Oct 30, 2025 | 2025 (Q3) | -0.15-0.13 | 0.2 | -165.00% (-0.33) | |
| Jul 30, 2025 | 2025 (Q2) | ―1.32 | 0.07 | 1938.46% (+1.26) | |
| Apr 24, 2025 | 2025 (Q1) | 0.32-0.11 | 0.12 | -191.67% (-0.23) | |
| Feb 28, 2025 | 2024 (Q4) | 0.971.04 | -0.38 | 375.00% (+1.43) | |
| Oct 29, 2024 | 2024 (Q3) | 0.200.20 | 0.08 | 150.00% (+0.12) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

